Pyrimethamine

Last updated

Pyrimethamine
Pyrimethamine2DACS.svg
Pyrimethamine-from-xtal-3D-bs-17.png
Clinical data
Pronunciation /ˌpɪrɪˈmɛθəmɪn/
Trade names Daraprim, others
AHFS/Drugs.com Monograph
MedlinePlus a601050
License data
Pregnancy
category
Routes of
administration 		By mouth
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability well-absorbed
Protein binding 87%
Metabolism Liver
Elimination half-life 96 hours
Excretion Kidney
Identifiers
  • 5-(4-chlorophenyl)-6-ethyl- 2,4-pyrimidinediamine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
CompTox Dashboard (EPA)
ECHA InfoCard 100.000.331 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C12H13ClN4
Molar mass 248.71 g·mol−1
3D model (JSmol)
Melting point 233 to 234 °C (451 to 453 °F)
  • Clc2ccc(c1c(nc(nc1CC)N)N)cc2
  • InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17) Yes check.svgY
  • Key:WKSAUQYGYAYLPV-UHFFFAOYSA-N Yes check.svgY
   (verify)

Pyrimethamine, sold under the brand name Daraprim among others, is a medication used with leucovorin (leucovorin is used to decrease side effects of pyrimethamine; it does not have intrinsic anti-parasitic activity) to treat the parasitic diseases toxoplasmosis and cystoisosporiasis. [3] [4] It is also used with dapsone as a second-line option to prevent Pneumocystis jiroveci pneumonia in people with HIV/AIDS. [3] It was previously used for malaria but is no longer recommended due to resistance. [3] Pyrimethamine is taken by mouth. [3]

Contents

Common side effects include gastrointestinal upset, severe allergic reactions, and bone marrow suppression. [3] It should not be used by people with folate deficiency that has resulted in anemia. [3] There is concern that it may increase the risk of cancer. [3] While occasionally used in pregnancy it is unclear if pyrimethamine is safe for the baby. [1] Pyrimethamine is classified as a folic acid antagonist. [3] It works by inhibiting folic acid metabolism and therefore the making of DNA. [3]

Pyrimethamine was discovered in 1952 and came into medical use in 1953. [3] [5] It is on the World Health Organization's List of Essential Medicines. [6] It was approved as a generic in the United States in February 2020. [7]

Medical uses

Pyrimethamine is typically given with a sulfonamide and folinic acid. [8]

It is used for the treatment of toxoplasmosis, actinomycosis, and isosporiasis, and for the treatment and prevention of Pneumocystis jirovecii pneumonia. [3]

Toxoplasmosis

Pyrimethamine is also used in combination with sulfadiazine to treat active toxoplasmosis. The two drugs bind the same enzymatic targets as the drugs trimethoprim and sulfamethoxazole - dihydrofolate reductase and dihydropteroate synthase, respectively.[ citation needed ]

Pyrimethamine has also been used in several trials to treat retinochoroiditis. [9]

Pregnancy consideration

Pyrimethamine is labeled as pregnancy category C in the United States. [1] [10] To date, not enough evidence on its risks in pregnancy or its effects on the fetus is available. [10] [11]

Malaria

It is primarily active against Plasmodium falciparum , but also against Plasmodium vivax . [12] Due to the emergence of pyrimethamine-resistant strains of P. falciparum, pyrimethamine alone is seldom used now. In combination with a long-acting sulfonamide such as sulfadiazine, it was widely used, such as in Fansidar, though resistance to this combination is increasing. [12]

Contraindications

Pyrimethamine is contraindicated in people with folate-deficiency anaemia. [8]

Side effects

When higher doses are used, as in the treatment of toxoplasmosis, pyrimethamine can cause gastrointestinal symptoms such as nausea, vomiting, glossitis, anorexia, and diarrhea. [11] [13] A rash, which can be indicative of a hypersensitivity reaction, is also seen, particularly in combination with sulfonamides. [11] Central nervous system effects include ataxia, tremors, and seizures. [13] Hematologic side effects such as thrombocytopenia, leukopenia, and anemia can also occur. [13]

Interactions

Other antifolate agents such as methotrexate and trimethoprim may potentiate the antifolate actions of pyrimethamine, leading to potential folate deficiency, anaemia, and other blood dyscrasias. [8]

Mechanism of action

Pyrimethamine interferes with the regeneration of tetrahydrofolic acid from dihydrofolate by competitively inhibiting the enzyme dihydrofolate reductase. [14] Tetrahydrofolic acid is essential for DNA and RNA synthesis in many species, including protozoa. [14] It has also been found to reduce the expression of SOD1, a key protein involved in amyotrophic lateral sclerosis. [15] [16]

Other medications

Pyrimethamine is typically given with folinic acid and sulfadiazine. [10]

Mechanism of resistance

Resistance to pyrimethamine is widespread. Mutations in the malarial gene for dihydrofolate reductase may reduce its effectiveness. [17] These mutations decrease the binding affinity between pyrimethamine and dihydrofolate reductase via loss of hydrogen bonds and steric interactions. [18]

History

Synthesis of pyrimethamine typically begins with p-chlorophenylacetonitrile, which undergoes a condensation reaction with ethyl propionate ester; the product of this then reacts with diazomethane to form an enol ether, which reacts with free guanidine in a second condensation reaction. Pyrimethamine traditional synthesis.png
Synthesis of pyrimethamine typically begins with p-chlorophenylacetonitrile, which undergoes a condensation reaction with ethyl propionate ester; the product of this then reacts with diazomethane to form an enol ether, which reacts with free guanidine in a second condensation reaction.

Nobel Prize-winning American scientist Gertrude Elion developed the drug at Burroughs-Wellcome (now part of GlaxoSmithKline) to combat malaria. [19] Pyrimethamine has been available since 1953. [20] In 2010, GlaxoSmithKline sold the marketing rights for Daraprim to CorePharma. Impax Laboratories sought to buy CorePharma in 2014, and completed the acquisition, including Daraprim, in March 2015. [21] In August 2015, the rights were bought by Turing Pharmaceuticals. [22] Turing subsequently became infamous for a price hike controversy when it raised the price of a dose of the drug in the U.S. market from US$13.50 to US$750, a 5,500% increase. [23]

Society and culture

Economics

In the United States in 2015, Turing Pharmaceuticals was criticized for increasing the price 50-fold, from US$13.50 to $750 a tablet, [24] leading to a cost of $75,000 for a course of treatment reported at one hospital. [25]

United States

In the United States, in 2015, with Turing Pharmaceuticals' acquisition of the US marketing rights for Daraprim tablets, [26] Daraprim became a single-source and specialty pharmacy item, and the price was increased. [27] The cost of a monthly course for a person on 75 mg dose rose to about $75,000/month at one hospital, or $750 per tablet while it was previously priced at $13.50. [28]

Outpatients could no longer obtain the medication from a community pharmacy, but only through a single dispensing pharmacy, Walgreens Specialty Pharmacy, and institutions could no longer order from their general wholesaler, but had to set up an account with the Daraprim Direct program. [27] [29] Presentations from Retrophin, a company formerly headed by Martin Shkreli, CEO of Turing, from which Turing acquired the rights to Daraprim, suggested that a closed distribution system could prevent generic competitors from legally obtaining the drugs for the bioequivalence studies required for FDA approval of a generic drug. [29]

Shkreli defended the price hike by saying, "If there was a company that was selling an Aston Martin at the price of a bicycle, and we buy that company and we ask to charge Toyota prices, I don't think that that should be a crime." [30] [31] As a result of the backlash, Shkreli hired a crisis public relations firm to help explain his fund's move. [32] Turing Pharmaceuticals announced on 24 November 2015, "that it would not reduce the list price of that drug after all", but they would offer patient assistance programs. [33] New York Times journalist Andrew Pollack noted that these programs "are standard for companies selling extremely high-priced drugs. They enable the patients to get the drug while pushing most of the costs onto insurance companies and taxpayers." [33]

The price increase was criticized by physician groups such as HIV Medicine Associates and Infectious Diseases Society of America. [34]

In 2016, a group of high school students from Sydney Grammar supported by the University of Sydney prepared pyrimethamine as an illustration that the synthesis is comparatively easy and the price-hike unjustifiable. His team produced 3.7 g for US$20, which would have been worth between US$35,000 and US$110,000 in the United States at the time. [35] Shkreli said the schoolboys were not competition, likely because the necessary bioequivalence studies require a sample of the existing medication provided directly by the company, and not simply purchased from a pharmacy, which Turing could decline to provide. [36] [37] Nonetheless, the students' work was featured in The Guardian [36] and Time magazine, [38] and on ABC Australia, [35] the BBC, [37] and CNN. [39]

On 22 October 2015, Imprimis Pharmaceuticals announced it had made available compounded and customizable formulations of pyrimethamine and leucovorin in capsules to be taken by mouth starting as low as $99 for a 100-count bottle in the United States. [40] Pyrimethamine was approved as a generic in the United States in February 2020. [7]

In January 2020, the FTC filed a case against Vyera "alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim". [41] A settlement was reached in December 2021. According to AP News, the settlement "requires Vyera and Phoenixus to provide up to $40 million in relief over 10 years to consumers who allegedly were fleeced by their actions and requires them to make Daraprim available to any potential generic competitor at the cost of producing the drug." [42] According to Law360, company executive Kevin Mulleady "agreed to a seven-year ban on working for or holding more than an 8% share in most pharmaceutical companies." [43]

Other countries

In India, multiple combinations of generic pyrimethamine are available for a price ranging from US$0.04 to US$0.10 each (3–7 rupees). [44] [45] [46] [47]

In the UK, the same drug is available from GSK at a cost of US$20 (£13) for 30 tablets (about $0.66 each). [48]

In Australia, the drug is available in most pharmacies at a cost of US$9.35 (A$12.99) for 50 tablets (around US$0.18 each). [49]

In Brazil, the drug is available for R$0.07 a pill, or about US$0.02. [50]

In Switzerland, the drug is available for US$9.45 (CHF9.05) for 30 tablets (around US$0.32 a piece). [51]

Research

In 2011, researchers discovered that pyrimethamine can increase β-hexosaminidase activity, thus potentially slowing down the progression of late-onset Tay–Sachs disease. [52] It is being evaluated in clinical trials as a treatment for amyotrophic lateral sclerosis. [53]

See also

Related Research Articles

<span class="mw-page-title-main">Folate</span> Vitamin B9; nutrient essential for DNA synthesis

Folate, also known as vitamin B9 and folacin, is one of the B vitamins. Manufactured folic acid, which is converted into folate by the body, is used as a dietary supplement and in food fortification as it is more stable during processing and storage. Folate is required for the body to make DNA and RNA and metabolise amino acids necessary for cell division and maturation of blood cells. As the human body cannot make folate, it is required in the diet, making it an essential nutrient. It occurs naturally in many foods. The recommended adult daily intake of folate in the U.S. is 400 micrograms from foods or dietary supplements.

<span class="mw-page-title-main">Trimethoprim</span> Antibiotic

Trimethoprim (TMP) is an antibiotic used mainly in the treatment of bladder infections. Other uses include for middle ear infections and travelers' diarrhea. With sulfamethoxazole or dapsone it may be used for Pneumocystis pneumonia in people with HIV/AIDS. It is taken orally.

<span class="mw-page-title-main">Sydney Grammar School</span> Grammar school in Sydney, Australia

Sydney Grammar School is an independent, non-denominational day school for boys, located in Sydney, Australia.

<span class="mw-page-title-main">Trimethoprim/sulfamethoxazole</span> Combination of two antibiotic drugs

Trimethoprim/sulfamethoxazole, sold under the brand name Bactrim among others, is a fixed-dose combination antibiotic medication used to treat a variety of bacterial infections. It consists of one part trimethoprim to five parts sulfamethoxazole. It is used to treat urinary tract infections, methicillin-resistant Staphylococcus aureus (MRSA) skin infections, travelers' diarrhea, respiratory tract infections, and cholera, among others. It is used both to treat and prevent pneumocystis pneumonia and toxoplasmosis in people with HIV/AIDS and other causes of immunosuppression. It can be given orally or intravenous infusion.

<span class="mw-page-title-main">Folinic acid</span> Derivative of folic acid used in cancer treatment

Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer, may be used to treat folate deficiency that results in anemia, and methanol poisoning. It is taken by mouth, injection into a muscle, or injection into a vein.

<span class="mw-page-title-main">Sulfamethoxazole</span> Chemical compound

Sulfamethoxazole is an antibiotic. It is used for bacterial infections such as urinary tract infections, bronchitis, and prostatitis and is effective against both gram negative and positive bacteria such as Escherichia coli and Listeria monocytogenes.

<span class="mw-page-title-main">Aminopterin</span> Chemical compound

Aminopterin, the 4–amino derivative of folic acid, is an antineoplastic drug with immunosuppressive properties often used in chemotherapy. Aminopterin is a synthetic derivative of pterin. Aminopterin works as an enzyme inhibitor by competing for the folate binding site of the enzyme dihydrofolate reductase. Its binding affinity for dihydrofolate reductase effectively blocks tetrahydrofolate synthesis. This results in the depletion of nucleotide precursors and inhibition of DNA, RNA, and protein synthesis.

<span class="mw-page-title-main">Pemetrexed</span> Chemical compound

Pemetrexed, sold under the brand name Alimta among others, is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC).

<span class="mw-page-title-main">Etacrynic acid</span> Chemical compound

Etacrynic acid (INN) or ethacrynic acid (USAN), trade name Edecrin, is a loop diuretic used to treat high blood pressure and the swelling caused by diseases like congestive heart failure, liver failure, and kidney failure. A con with ethacrynic acid compared to the other loop diuretic drugs such as furosemide is that it has a significantly steep dose-response curve, which means the drug's dosing is very important as small variance in dose can cause a significant difference in the biological response.

<span class="mw-page-title-main">Sulfadiazine</span> Chemical compound

Sulfadiazine is an antibiotic. Used together with pyrimethamine, a dihydrofolate reductase inhibitor, it is the treatment of choice for toxoplasmosis, which is caused by a protozoan parasite. It is a second-line treatment for otitis media, prophylaxis of rheumatic fever, chancroid, chlamydia, and infections by Haemophilus influenzae. It is also used as adjunct therapy for chloroquine-resistant malaria and several forms of bacterial meningitis. It is taken by mouth. Sulfadiazine is available in multiple generic tablets of 500 mg. For urinary tract infections, the usual dose is 4 to 6 grams daily in 3 to 6 divided doses.

<span class="mw-page-title-main">Tetrahydrofolic acid</span> Chemical compound

Tetrahydrofolic acid (THFA), or tetrahydrofolate, is a folic acid derivative.

<span class="mw-page-title-main">Sulfadimethoxine</span> Chemical compound

Sulfadimethoxine is a long-lasting sulfonamide antimicrobial medication used in veterinary medicine. It is used to treat many infections, including respiratory, urinary tract, enteric, and soft tissue infections and can be given as a standalone or combined with ormetoprim to broaden the target range. Like all sulfamides, sulfadimethoxine inhibits bacterial synthesis of folic acid by acting as a competitive inhibitor against PABA. It is the most common drug prescribed to dogs who have coccidiosis.

<span class="mw-page-title-main">Antifolate</span> Class of antimetabolite medications

Antifolates are a class of antimetabolite medications that antagonise (that is, block) the actions of folic acid (vitamin B9). Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis. Consequently, antifolates inhibit cell division, DNA/RNA synthesis and repair and protein synthesis. Some such as proguanil, pyrimethamine and trimethoprim selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. The majority of antifolates work by inhibiting dihydrofolate reductase (DHFR).

Medication costs, also known as drug costs are a common health care cost for many people and health care systems. Prescription costs are the costs to the end consumer. Medication costs are influenced by multiple factors such as patents, stakeholder influence, and marketing expenses. A number of countries including Canada, parts of Europe, and Brazil use external reference pricing as a means to compare drug prices and to determine a base price for a particular medication. Other countries use pharmacoeconomics, which looks at the cost/benefit of a product in terms of quality of life, alternative treatments, and cost reduction or avoidance in other parts of the health care system. Structures like the UK's National Institute for Health and Clinical Excellence and to a lesser extent Canada's Common Drug Review evaluate products in this way.

Sulfadoxine/pyrimethamine, sold under the brand name Fansidar, is a combination medication used to treat malaria. It contains sulfadoxine and pyrimethamine. For the treatment of malaria it is typically used along with other antimalarial medication such as artesunate. In areas of Africa with moderate to high rates of malaria, three doses are recommended during the second and third trimester of pregnancy.

<span class="mw-page-title-main">Martin Shkreli</span> American financial investor and businessman (born 1983)

Martin Shkreli is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

<span class="mw-page-title-main">Vyera Pharmaceuticals</span> Pharmaceutical company

Vyera Pharmaceuticals is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

<span class="mw-page-title-main">Alice Motion</span> British chemist and science communicator (born 1984)

Alice Elizabeth Motion is a British chemist, science communicator, and associate professor at the School of Chemistry, University of Sydney. She is the founder of the Breaking Good project which encourages high school and undergraduate students to take part in research that can benefit human health. In 2018, the Breaking Good project was a finalist on the Google.org Impact Challenge.

<span class="mw-page-title-main">Matthew Todd (chemist)</span> British chemist (born 1973)

Matthew Houghton Todd is a British chemist and the Professor and Chair of Drug Discovery of the School of Pharmacy at University College London. He is the founder of Open Source Malaria (OSM) and his research focuses on drug discovery and development for this disease. Recently, he has expanded to other areas, particularly neglected diseases such as tuberculosis and mycetoma in the Open Source Tuberculosis (OSTB) and Open Source Mycetoma (MycetOS) project, through a collaboration with the Drugs for Neglected Diseases Initiative and Erasmus MC. In addition, he has some research activity in catalysis and methodology.

References

  1. 1 2 3 "Pyrimethamine (Daraprim) Use During Pregnancy". Drugs.com. 31 July 2019. Archived from the original on 3 December 2016. Retrieved 28 February 2020.
  2. ↑ "Daraprim Tablets – Summary of Product Characteristics (SmPC)". (emc). 19 February 2020. Archived from the original on 29 February 2020. Retrieved 28 February 2020.
  3. 1 2 3 4 5 6 7 8 9 10 11 "Pyrimethamine". The American Society of Health-System Pharmacists. Archived from the original on 2 December 2016. Retrieved 2 December 2016.
  4. ↑ Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 54. ISBN   9781284057560.
  5. ↑ Sylvie M, Pierre C, Jean M (2008). Biodiversity of Malaria in the world. John Libbey Eurotext. p. 6. ISBN   9782742009633. Archived from the original on 14 January 2023. Retrieved 10 September 2017.
  6. ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  7. 1 2 "FDA Approves First Generic of Daraprim". U.S. Food and Drug Administration (FDA) (Press release). 28 February 2020. Archived from the original on 29 February 2020. Retrieved 28 February 2020.
  8. 1 2 3 Rossi S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN   978-0-9805790-9-3.
  9. ↑ Pradhan E, Bhandari S, Gilbert RE, Stanford M (May 2016). "Antibiotics versus no treatment for toxoplasma retinochoroiditis". The Cochrane Database of Systematic Reviews. 2016 (5): CD002218. doi:10.1002/14651858.CD002218.pub2. PMC   7100541 . PMID   27198629.
  10. 1 2 3 "Daraprim- pyrimethamine tablet". DailyMed. 31 August 2017. Archived from the original on 3 August 2020. Retrieved 28 February 2020.
  11. 1 2 3 "Pyrimethamine | FDA Label - Tablet". AIDSinfo. Archived from the original on 18 January 2017. Retrieved 7 November 2016.
  12. 1 2 Brayfield A, ed. (13 December 2013). "Pyrimethamine". Martindale: The Complete Drug Reference. Pharmaceutical Press. Archived from the original on 29 August 2021. Retrieved 12 April 2014.
  13. 1 2 3 "Daraprim Side Effects in Detail". www.drugs.com. Archived from the original on 8 November 2016. Retrieved 7 November 2016.
  14. 1 2 "Product Information Daraprim Tablets". TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 5 December 2011. p. 1. Archived from the original on 5 October 2016. Retrieved 12 April 2014.
  15. ↑ Limpert AS, Mattmann ME, Cosford ND (2013). "Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)" (PDF). Beilstein Journal of Organic Chemistry. 9: 717–732. doi:10.3762/bjoc.9.82. PMC   3678841 . PMID   23766784. Archived (PDF) from the original on 13 April 2014.
  16. ↑ Lange DJ, Andersen PM, Remanan R, Marklund S, Benjamin D (April 2013). "Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot study". Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14 (3): 199–204. doi:10.3109/17482968.2012.724074. PMID   22985433. S2CID   39846211.
  17. ↑ Gatton ML, Martin LB, Cheng Q (June 2004). "Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum". Antimicrobial Agents and Chemotherapy. 48 (6): 2116–2123. doi:10.1128/AAC.48.6.2116-2123.2004. PMC   415611 . PMID   15155209.
  18. ↑ Sirichaiwat C, Intaraudom C, Kamchonwongpaisan S, Vanichtanankul J, Thebtaranonth Y, Yuthavong Y (January 2004). "Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum". Journal of Medicinal Chemistry. 47 (2): 345–354. doi:10.1021/jm0303352. PMID   14711307.
  19. ↑ Vasudevan DM, Sreekumari S, Vaidyanathan K (2013). Textbook of Biochemistry for Medical Students. JP Medical Ltd. p. 491. ISBN   9789350905302. OCLC   843532694. Archived from the original on 8 September 2017. Retrieved 15 January 2016.
  20. ↑ Cha AE (22 September 2015). "CEO who raised price of old pill more than $700 calls journalist a 'moron' for asking why". The Washington Post . Archived from the original on 23 September 2015.
  21. ↑ Pollack A (20 September 2015). "Drug Goes From $13.50 a Tablet to $750, Overnight". The New York Times . Archived from the original on 16 December 2015. Retrieved 17 December 2015.
  22. ↑ LaMattina J (21 September 2015). "Here's A Way For Pharma To Prevent Outrageous Generic Price Increases – And Help Its Reputation". Forbes . Archived from the original on 23 September 2015.
  23. ↑ Kliff S (22 September 2015). "Vox Explainers: A Drug Company Raised a Pill's Price 5,500 Percent Because, in America, It Can". Vox. Archived from the original on 10 December 2015. Retrieved 9 December 2015.
  24. ↑ Pollack A (20 September 2015). "Drug Goes From $13.50 a Tablet to $750, Overnight". The New York Times. Archived from the original on 16 December 2015. Retrieved 31 March 2020. Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars.
  25. ↑ Alpern JD, Song J, Stauffer WM (May 2016). "Essential Medicines in the United States--Why Access Is Diminishing". The New England Journal of Medicine. 374 (20): 1904–1907. doi:10.1056/nejmp1601559. PMID   27192669. Heavy scrutiny followed, and although Turing agreed to reduce the price, the drug remains prohibitively expensive for many patients. Recently, at our hospital, an immigrant patient with a new diagnosis of HIV– AIDS and toxoplasmosis couldn't receive first-line therapy because of cost: the price for 100 pills was $75,000.
  26. ↑ "Turing Pharmaceuticals AG Acquires U.S. Marketing Rights to Daraprim (pyrimethamine)". Turing Pharmaceuticals AG. PR Newswire Association LLC. 10 August 2015. Archived from the original on 22 September 2015.
  27. 1 2 Mahoney MV (17 July 2015). "New Pyrimethamine Dispensing Program: What Pharmacists Should Know". PharmacyTimes. Archived from the original on 6 September 2015.
  28. ↑ Pollack A (20 September 2015). "Drug Goes From $13.50 a Tablet to $750, Overnight". The New York Times. Archived from the original on 25 September 2015. Retrieved 21 September 2015.
  29. 1 2 Lowe D (11 September 2014). "The Most Unconscionable Drug Price Hike I Have Yet Seen". In the Pipeline. Archived from the original on 7 June 2016.
  30. ↑ Ramsey L (22 September 2015). "A pharma CEO tried to defend his decision to jack up the price of a critical drug by 5,000% – and it backfired". Business Insider. Archived from the original on 10 October 2015.
  31. ↑ "Company hikes price of popular drug". Reuters. 22 September 2015. Archived from the original on 2 October 2015.
  32. ↑ Tannahill J (9 October 2015). "PR Man Allan Ripp Representing The "Most Hated Man in America"". EverythingPR. Archived from the original on 14 October 2015.
  33. 1 2 Pollack A (24 November 2015). "Turing Refuses to Lower List Price of Toxoplasmosis Drug". New York Times. Archived from the original on 8 September 2017. Retrieved 25 November 2015.
  34. ↑ "Letter to Tom Evegan and Kevin Burnier" (PDF). Archived from the original (PDF) on 23 September 2015. Retrieved 23 September 2015.
  35. 1 2 Hunjan R (30 November 2016). "Daraprim drug's key ingredient recreated by high school students in Sydney for just $20". ABC News . Archived from the original on 4 April 2019. Retrieved 23 April 2019.
  36. 1 2 Davey M (1 December 2016). "Australian students recreate Martin Shkreli price-hike drug in school lab". The Guardian . Archived from the original on 1 December 2016. Retrieved 1 December 2016.
  37. 1 2 Dunlop G (1 December 2016). "Australian boys recreate life-saving drug". BBC News . Archived from the original on 1 December 2016. Retrieved 1 December 2016.
  38. ↑ Lui K (2 December 2016). "Watch Martin Shkreli Respond to the School Kids Who Recreated His Drug for $2 a Dose". Time . Archived from the original on 3 November 2020. Retrieved 23 April 2019.
  39. ↑ Roberts E (1 December 2016). "'Pharma Bro' Martin Shkreli meets his match in a group of Australian schoolboys". CNN . Archived from the original on 23 April 2019. Retrieved 23 April 2019.
  40. ↑ "Express Scripts, Imprimis to offer $1 Daraprim alternative". CNBC . December 2015. Archived from the original on 7 August 2020. Retrieved 1 April 2020.
  41. ↑ "Vyera Pharmaceuticals, LLC". Federal Trade Commission . 27 January 2020. Archived from the original on 9 December 2021. Retrieved 9 December 2021.
  42. ↑ "'Pharma Bro' firm reaches $40M settlement in gouging case". AP News . 8 December 2021. Archived from the original on 9 December 2021. Retrieved 9 December 2021.
  43. ↑ Koenig B (7 December 2021). "Former Shkreli Co. Inks Deal Worth Up To $40M With FTC, AGs - Law360". Law360 . Archived from the original on 9 December 2021. Retrieved 9 December 2021.
  44. ↑ Miseta E (29 September 2015). "High Drug Prices: Should We Blame Pharma Or The FDA?". Clinical Leader. Archived from the original on 30 September 2015.
  45. ↑ "Medline India – Sulfadoxine with Pyrimethamine". www.medlineindia.com. Archived from the original on 24 September 2015. Retrieved 22 September 2015.
  46. ↑ "It is Cheaper for an American patient to fly out to India and buy a year's supply of the medication than buy a single Daraprim tablet in the US". 25 September 2015. Archived from the original on 28 September 2015.
  47. ↑ "There is no reason why the United States cannot have as vigorous a market in generic pharmaceuticals as does India". 24 September 2015. Archived from the original on 6 October 2015.
  48. ↑ Roberts M (22 September 2015). "What's a fair price for a drug?". BBC News. Archived from the original on 24 September 2015. Retrieved 23 September 2015.
  49. ↑ "Chemist Warehouse". www.chemistwarehouse.com.au. Archived from the original on 22 December 2015. Retrieved 12 December 2015.
  50. ↑ "Remédio que teve aumento de 5.000% nos EUA custa R$ 0,07 no Brasil (e não vai aumentar)". brasilpost.com.br. Archived from the original on 25 September 2015. Retrieved 23 September 2015.
  51. ↑ "Swiss Compendium information about Daraprim". compendium.ch. Archived from the original on 29 August 2021. Retrieved 1 September 2017.
  52. ↑ Osher E, Fattal-Valevski A, Sagie L, Urshanski N, Amir-Levi Y, Katzburg S, et al. (March 2011). "Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs". Molecular Genetics and Metabolism. 102 (3): 356–363. doi:10.1016/j.ymgme.2010.11.163. PMID   21185210.
  53. ↑ Clinical trial number NCT01083667 for "SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)" at ClinicalTrials.gov
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.